4//SEC Filing
Sage Therapeutics, Inc. 4
Accession 0001562180-16-002140
CIK 0001597553operating
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 1:53 PM ET
Size
10.7 KB
Accession
0001562180-16-002140
Insider Transaction Report
Form 4
Kanes Stephen
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2016-04-20$0.45/sh+21,000$9,450→ 46,948 total - Sale
Common Stock
2016-04-19$38.00/sh−21,000$798,000→ 25,948 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-04-20−21,000→ 112,100 totalExercise: $0.45Exp: 2023-07-23→ Common Stock (21,000 underlying)
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]This transaction was executed in multiple trades at prices ranging from $38.00 USD to $38.01 USD. The price reported above reflects the weighted average sale price.
- [F3]25% 1 year cliff then evenly for the remaining 36 months beginning on 18-Jul-2013.
Documents
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001597553
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 1:53 PM ET
- Size
- 10.7 KB